trending Market Intelligence /marketintelligence/en/news-insights/trending/dyhnrmkbkuz24qfpuzx9wa2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Aeglea BioTherapeutics appoints director

Blog

JMP Securities is Now Available in the S&P Global Market Intelligence Aftermarket Research Collection

Blog

M&A rebound sparks optimism for near-term deal activity

Blog

Needham & Company is Now Available in the S&P Global Market Intelligence Aftermarket Research Collection

Blog

Banking Essentials Newsletter - February Edition


Aeglea BioTherapeutics appoints director

Aeglea Biotherapeutics Inc. appointed Ivana Magovcevic-Liebisch as a director.

Magovcevic-Liebisch is the executive vice president and chief business officer of Ipsen SA, a global biopharmaceutical company.

Austin, Texas-based Aeglea Biotherapeutics is a biotechnology company that designs and develops innovative human enzyme therapeutics for patients with rare genetic diseases and cancer.